Anti-invasive and metastatic activities of evodiamine

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 11, 2002, Pages 1491-1493

  Ogasawara, Masaru ^a   Matsunaga, Takayuki ^a   Takahashi, Satoshi ^a   Saiki, Ikuo ^b   Suzuki, Hideyo ^a  

^a Toyama Prefectural Institute for Pharmaceutical Research   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Evodiamine; Invasion; Metastasis; Migration; Tumor cell

Indexed keywords

2 MERCAPTO 4(3H) QUINAZOLINONE; ANTIMETASTATIC AGENT; EVODIAMINE; HYDROGEN; INDOLE; METHYL GROUP; QUINAZOLINONE DERIVATIVE; RESERPINE; RUTAECARPINE; UNCLASSIFIED DRUG; YOHIMBINE; ANTINEOPLASTIC AGENT; EVODIA FRUIT; PLANT EXTRACT; QUINAZOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; IC 50; LEWIS CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; MELANOMA; MELANOMA B16; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; TUMOR CELL; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CHEMISTRY; COLON TUMOR; DRUG EFFECT; EXPERIMENTAL MELANOMA; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; COLONIC NEOPLASMS; EVODIA; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; QUINAZOLINES;

EID: 0242275764     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1491     Document Type: Article

References (24)

1. Chambers A. F., MacDonald I. C., Schmidt E. E., Morris V. L., Groom A. C., Adv. Cancer Res., 79, 91-121 (2000).
2. Poste G., Fidler I. J., Nature (London), 283, 139-146 (1980).
3. Mochizuki M., Yoo Y. C., Yudoh K., Matsuno H., Kimura T., J. Lab. Clin. Med., 133, 120-128 (1999).
4. Mishima T., Murata J., Toyoshima M., Fujii H., Nakajima M., Hayashi T., Kalo T., Saiki I., Clin. Exp. Metastasis, 16, 541-550 (1998).
5. Yip D., Ahmad A., Karapetis C. S., Hawkins C. A., Harper P. G., Invest. New Drugs, 17, 387-399 (1999).
6. Jones L., Ghaneh P., Humphreys M., Neoptolems J. P., Ann. N. Y. Acad. Sci., 880, 288-307 (1999).
7. Menon L. G., Kuttan R., Kuttan G., Cancer Lett., 141, 159-165 (1999).
8. Ito K., Yoshioka K., Akedo H., Uehala M., Ishizaki T., Narumiya S., Nature Med., 5, 221-225 (1999).
9. Kuramitsu Y., Hamada J., Tsuruoka T., Moriokawa K., Kobayashi H., Hosokawa M., Anticancer Drugs, 9, 88-92 (1998).
10. Ogasawara M., Matsubara T., Suzuki H., Biol. Pharm. Bull., 24, 917-920 (2001).
11. Shoji N., Ueyama A., Takemoto T., Kajiyama A., Ohizumi Y., J. Pharm. Sci., 75, 612-613 (1986).
12. Itokawa Y., Inamatsu M., Takaya K., Jpn. J. Pharmacog., 44, 135-137 (1990).
13. Hung P. H., Lin L. C., Wang G. J., Chen C. F., Wang P. S., Chin. J. Physiol., 44, 53-57 (2001).
14. Kobayashi Y., Nakano Y., Kizaki M., Hoshikuma K., Yokoo Y., Kamiya T., Planta Med., 67, 628-633 (2001).
15. Kobayashi Y., Nakano Y., Hoshikuma K., Yokoo Y., Kamiya T., Planta Med., 66, 526-530 (2000).
16. Matsuda H., Wu J. X., Tanaka T., Iinuma M., Kubo M., Biol. Pharm. Bull., 20, 243-248 (1997).
17. Chiou W. F., Chou C. J., Shum A. Y., Chen C. F., Eur. J. Pharmacol., 215, 277-283 (1992).
18. Yoshizuni M., Houchi H., Ishimura Y., Hirose M., Kitagawa T., Tsuchiya K., Minakuchi K., Tamaki T., J. Med. Invest., 44, 79-82 (1997).
19. Chiou W. F., Sung Y. J., Liao J. F., Shum A. Y., Chen C. F., J. Nat. Prod., 60, 708-711 (1997).
20. Saito K., Oku T., Ata N., Miyashiro H., Hattori M., Saiki I., Biol. Pharm. Bull., 20, 345-348 (1997).
21. Ogasawara M., Matsubara T., Suzuki H., Biol. Pharm. Bull., 24, 720-723 (2001).
22. Singh R. K., Tsan R., Radinsky R., Clin. Exp. Metastasis, 15, 140-150 (1997).
23. Wach F., Eyrich A. M., Wustrow T., Kreig T., Hein R., J. Dermatol. Sci., 12, 118-126 (1996).
24. Murata J., Ayukawa K., Ogasawara M., Fujii H., Saiki I., Invasion Metastasis, 17, 82-93 (1997).